
1.Antiadrenergic agents ( Antisympathetic drugs / Sympatholytics ) Non-Selective Alpha Blockers
Dr.G Bhanu Prakash Animated Medical Videos
Overview
This video explains sympatholytic drugs, specifically focusing on non-selective alpha-adrenergic blockers. It details how these drugs work by blocking both alpha-1 and alpha-2 receptors, leading to vasodilation and potential postural hypotension due to alpha-1 blockade. The video also discusses the reflex increase in sympathetic outflow and tachycardia caused by alpha-2 blockade. A key phenomenon, the vasomotor reversal of Dale, is explained, illustrating how prior administration of non-selective alpha-blockers alters the blood pressure response to adrenaline. Finally, the clinical uses of irreversible (phenoxybenzamine) and reversible (phentolamine, tolazoline) non-selective alpha-blockers are presented, including their roles in managing pheochromocytoma and hypertensive crises.
Save this permanently with flashcards, quizzes, and AI chat
Chapters
- Sympatholytic drugs counteract the effects of the sympathetic nervous system.
- These drugs primarily work by blocking alpha and beta adrenergic receptors.
- Alpha blockers are categorized into non-selective (blocking both alpha-1 and alpha-2) and selective (blocking either alpha-1 or alpha-2) types.
- Non-selective alpha blockers bind to both alpha-1 and alpha-2 receptors.
- They are further classified into irreversible (e.g., phenoxybenzamine) and reversible (e.g., phentolamine, tolazoline) antagonists.
- Irreversible blockers form a permanent bond with the receptor, while reversible blockers can be displaced.
- Stimulation of alpha-1 receptors normally causes vasoconstriction.
- Blocking alpha-1 receptors leads to vasodilation (widening of blood vessels).
- This vasodilation can result in a drop in blood pressure, particularly when changing posture (postural hypotension).
- Alpha-2 receptors, located in the central nervous system, normally reduce sympathetic outflow when stimulated.
- Blocking alpha-2 receptors removes this inhibitory signal.
- This leads to a reflex increase in sympathetic discharge and tone, causing increased heart rate (tachycardia).
- Normally, intravenous adrenaline causes an initial rise in blood pressure (alpha-1 effect) followed by a fall (beta-2 effect).
- When non-selective alpha blockers are given *before* adrenaline, the alpha-1 mediated pressor response is blocked.
- Consequently, only the beta-2 mediated vasodilation effect is observed, resulting in a pronounced fall in blood pressure, known as the vasomotor reversal of Dale.
- Phenoxybenzamine (irreversible) is used to prevent hypertensive episodes during surgery for pheochromocytoma.
- Phentolamine and tolazoline (reversible) are used to treat hypertensive crises associated with clonidine withdrawal.
- These reversible agents are also used in managing 'cheese reactions' (hypertensive crisis after consuming tyramine-rich foods while on MAO inhibitors).
Key takeaways
- Non-selective alpha blockers interfere with the sympathetic nervous system by blocking both alpha-1 and alpha-2 receptors.
- Alpha-1 blockade causes vasodilation and can lead to postural hypotension.
- Alpha-2 blockade results in increased sympathetic outflow and reflex tachycardia.
- The vasomotor reversal of Dale illustrates how alpha-blockade alters the cardiovascular response to adrenaline.
- Irreversible non-selective alpha blockers like phenoxybenzamine are used for specific perioperative management of conditions like pheochromocytoma.
- Reversible non-selective alpha blockers like phentolamine are crucial for managing acute hypertensive crises in certain clinical scenarios.
Key terms
Test your understanding
- How do non-selective alpha blockers differ from selective alpha blockers in their receptor targets?
- Explain the physiological consequences of blocking alpha-1 receptors versus alpha-2 receptors.
- What is postural hypotension, and why is it a common side effect of alpha-1 blockade?
- Describe the phenomenon of vasomotor reversal of Dale and the underlying mechanism.
- In what specific clinical situations are irreversible and reversible non-selective alpha blockers utilized?